We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA May Speed Drug Ad Review For Fee

Law360 (November 21, 2006, 12:00 AM EST) -- The U.S. Food and Drug Administration has reached a tentative agreement with pharmaceutical companies that would allow companies to pay the FDA fees to inspect their television ads in exchange for a speedier review.

Fees from the deal would help pay for the new staff needed to review the industry’s TV ads, the Wall Street Journal reported.

The FDA's Division of Drug Marketing, Advertising and Communications was recently restructured to address the ever-increasing workload of reviewing direct-to-consumer advertising materials.

In early September, the original DTC review...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.